1. Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
    Paulo Alexandre Ribeiro Mora et al, 2019, Gynecologic Oncology CrossRef
  2. Management of trophoblastic tumors : review of evidence, current practice, and future directions
    Antoine Deleuze et al, 2023, Expert Review of Anticancer Therapy CrossRef
  3. Current chemotherapeutic options for the treatment of gestational trophoblastic disease
    Antonio Braga et al, 2023, Expert Opinion on Pharmacotherapy CrossRef
  4. Case report: Multidrug resistant gestational trophoblastic neoplasia: focus on failure of immunotherapy and success of high-dose chemotherapy
    Anne Enuset et al, 2024, Frontiers in Oncology CrossRef
  5. High-Risk Gestational Trophoblastic Neoplasia
    K. Kalaichelvi, 2021, Gestational Trophoblastic Disease CrossRef
  6. Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
    Nadeem R. Abu-Rustum et al, 2019, Journal of the National Comprehensive Cancer Network CrossRef
  7. Influence of cord blood serum and actovegin on the reproductive function of cows in the comparative aspect
    Irina Bondarenko et al, 2021, EUREKA: Health Sciences CrossRef
  8. The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia
    M.M. Frijstein et al, 2019, European Journal of Cancer CrossRef
  9. Epidemiologic study on gestational trophoblastic diseases in Japan
    Eiko Yamamoto et al, 2022, Journal of Gynecologic Oncology CrossRef
  10. The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia
    Shizuka Sato et al, 2020, International Journal of Clinical Oncology CrossRef
  11. A case of complete remission of intractable gestational choriocarcinoma with subsequent chemotherapy after pembrolizumab
    Kaoru Niimi et al, 2023, Taiwanese Journal of Obstetrics and Gynecology CrossRef
  12. Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN)
    Giorgia Mangili et al, 2022, Cancers CrossRef